SYNC.LSE

Syncona Limited

SYNC.LSE, UK

Syncona Limited is a fund specializes in investments in hedge, equity and long-term alternative investment funds across multiple asset classes. It manages private equity, debt, fixed income and alternative investments. The fund prefers to invest in healthcare and life sciences sector with focus on Cell therapy, gene therapy, biologics and small molecules. The fund invests in the public equity and fixed income markets across the globe. It targets attractive medium to long term returns by investing in leading long-only and alternative investment funds with proven managers and across multiple asset classes. The firm invests in separately managed account portfolios.

https://www.synconaltd.com

Stock Price

GBp 0.00

0%

increase compared to yesterday.

Dividend

Frequency:

N/A

Rate:

N/A

Next Payout:

N/A
SYNC.LSE
stock
SYNC.LSE

Syncona Highlights Autolus Therapeutics’ Q3 2025 Financial Performance and Strategic Growth TipRanks

Read more →
SYNC.LSE
stock
SYNC.LSE

How London Stock Exchange Group migrated 30 PB of market data using AWS DataSync Amazon Web Services (AWS)

Read more →

Showing 2 of 3

Analyst Ratings & Sentiment

(Last Updated 2025-09-30)

Rating:

BUY

$

Analyst Picks

Strong Buy

0

Buy

3

Hold

0

Sell

0

Strong Sell

0

Finn Analysis

(Last Updated 2025-09-30)

Health Score

Price to Book Ratio (P/B)

-

Very High

59.40

Low ≤ 1

High ≥ 3

Return on Equity (ROE)

-

Very Low

-2.49 %

Low ≤ 5%

High ≥ 25%

Return on Assets (ROA)

-

Very Low

-2.46 %

Low ≤ 2%

High ≥ 10%

Free Cash Flow - Revenue % (FCF)

-

Very High

29.39 %

Low ≤ 5%

High ≥ 15%

Debt to Equity

-

Very High

0.01

Low ≥ 1

High ≤ 0.3

Investors

* Institutions hold a combined 0.00% of the total shares of Syncona Limited

* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.

Earnings History

EPS ActualEPS EstimateEPS DifferenceSurprise Percent

Upcoming Earnings Release

Date

2026-03-31

EPS Estimate

—

Latest Release

Date

—

EPS Actual

—

EPS Estimate

—

EPS Difference

—

Surprise Percent

undefined%

Investing Fit Scorecard

(Last Updated 2025-09-30)

Deep Value
Potential Value Candidate(5)
Defensive
Moderately Defensive(5)
Dividend
Weak Dividend Profile(3)
Economic Moat
Wide Moat Company(6.8)
GARP
Fair GARP(4)
Growth
Weak Growth Prospect(2.5)
Momentum
Moderate Momentum(4.5)
Net Net
Possible Net-Net(4)
Quality
Moderate Quality(4.5)
Value
Fair Value(3.5)

Income Statement

(Last Updated 2025-09-30)

Revenue

ÂŁ 0

Cost Of Revenue

ÂŁ 0

Gross Profit

ÂŁ 0

Operating Expenses

ÂŁ 0

Operating Income

ÂŁ 0

Interest Expense

ÂŁ 0

Pretax Income

ÂŁ 0

Net Income

ÂŁ 0

Income Tax Expense

ÂŁ 0

EBITDA

ÂŁ 0

Total Other Income Expense Net

ÂŁ 0

Earnings Per Share

0

Dividends Per Share

0

Shares Outstanding

0

Operating Margin

0%

Trend

Balance Sheet

(Last Updated 2025-09-30)

Cash

ÂŁ 0

Short Term Investments

ÂŁ 0

Receivables

ÂŁ 0

Inventories

ÂŁ 0

Total Current Assets

ÂŁ 0

Property Plant Equipment

ÂŁ 0

Total Assets

ÂŁ 0

Payables

ÂŁ 0

Short Term Debt

ÂŁ 0

Long Term Debt

ÂŁ 0

Total Liabilities

ÂŁ 0

Equity

ÂŁ 0

Trend

Cash Flow

(Last Updated 2025-09-30)

Net Income

ÂŁ 0

Depreciation

ÂŁ 0

Change In Working Capital

ÂŁ 0

Cash From Operations

ÂŁ 0

Capital Expenditures

ÂŁ 0

Cash From Investing

ÂŁ 0

Cash From Financing

ÂŁ 0

Net Change In Cash

ÂŁ 0

Trend

Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.